Our Team

---

Co-founder, Chief Executive Officer

Caghan Kizil is a W2 tenured professor of neuroscience at German Center for Neurodegenerative Diseases (DZNE) within Helmholtz Association in Dresden, Germany and Visiting  Professor at Columbia University Irving Medical Center, New York, USA. His research focuses on understanding the molecular mechanisms of regeneration in nervous system after neurodegeneration by using animal models and in vitro 3D human brain cultures. He received several awards including Helmholtz Young Investigator Award, Helmholtz Validation Funds of the President's Initiative, DZNE Innovation-to-Application Award, and Columbia University Schaefer Research Scholars Award. 

Co-founder, Scientific Advisor

Carsten Werner is a professor for Biofunctional Polymer Materials at the Technische Universität Dresden, Center for Regenerative Therapies Dresden and directs the Biomaterials program at the Leibniz Institute of Polymer Research Dresden/Max Bergmann Center of Biomaterials Dresden (Germany). His research aims at recapitulating functionalities of living matter in engineered polymer materials and includes studies on electrosurface phenomena, hemocompatibility of biomaterials and cell-instructive materials platforms for regenerative therapies and tissue models.

Co-founder

Uwe Freudenberg is a group leader for Matrix Engineering at the Institute of Biofunctional Polymer Materials at the Leibniz Institute of Polymer Research Dresden, Germany (IPF). He received his doctoral degree (Dr.-Ing.) from the Faculty of Mechanical Science and Engineering at the Technische Universität Dresden in 2007. His current research focuses on the development of multifunctional polymer materials for biomedical applications with special emphasis on GAG-based hydrogels.

...

Senior R&D Associate

Stanislava  Popova received her PhD degree from the Faculty of Medicine  "Carl Gustav Carus" at the Technische Universität Dresden and performed her postdoctoral research in German Center for Neurodegenerative Diseases (DZNE). Her expertise includes gene silencing, genomic engineering, recombinant technologies, 3D hydrogel cultures, cell-based metabolic assays, animal models of disease, and high-throughput assay automation and optimization.  

...

R&D Associate

Rajvinder Kaur is a neurobiologist, received her Ph.D. degree from the Faculty of Biology at the Technische Universität Darmstadt, Germany. Her cross-disciplinary research expertise includes pharmacological modulators and ionizing radiation, neuronal activity and plasticity, 2D and 3D mammalian cell culture systems, stem cell differentiation, cell-based  biochemical assays, array-based extracellular recordings, animal research, and imaging. 

Market Strategy Consultant

Klara Czobor is an accomplished medical communications specialist, pharmaceutical analyst, and medical/scientific reporter. She has been responsible for the development of a number of high-profile disease-state and branded promotional materials targeting a variety of key clinical and pharmaceutical audiences. Klara's responsibilities as a pharmaceutical analyst and reporter have included conducting interviews with KOLs, regulatory officials, and executives, and attending conferences to provide real-time clinical/regulatory medical information to pharmaceutical companies and investors. She has a comprehensive knowledge of the clinical profiles and marketing strategies that support multiple diverse pharmaceutical products. Klara is founder and CEO of Premier Endpoint and is the President of PharmaAcuity.  

Market Strategy Consultant

Ezgi Eris has over 10 years of pharmaceutical experience in medical strategy development, KOL relationship management, medical projects, clinical research, and drug safety. She was a hematology/ oncology MSL at Celgene for 9 years. She later served within the business strategy department of a healthcare agency that focuses on developing promotional materials in the area of neurological diseases. 

Strategic Advisor

Dr. N. Govindarajan works as Research and Innovation Manager at the German Cancer Research Center (DKFZ) in Heidelberg, Germany, bridging the fields of Artificial Intelligence and Life Sciences. Govind brings to our team his decade-long research experience in neurodegeneration along with many years of work experience in grants consultancy, R&D, and business strategies to ensure our lasting impact on the drug development technology landscape.